Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > busy times here...

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Feb 08, 2021 10:41am

212 Views

Post# 32500188

RE:RE:RE:RE:RE:RE:RE:busy times here...

Investors have to consider where our valuation should be now that it’s obvious a functional device will be the limiting factor. Should it be trading at 1/3 of those with preclinical cells? Something with Sigilion would be an appetizer. Sernova is focused on the big prize diabetes. Vertex may be interested in it for their semma cells. What puts sernova in such a powerful position to negotiate is there is no reason they can't go at it alone for all 3 indications.

<< Previous

Bullboard Posts

Next >>

First Nations contributions attract investor interest